Invention Grant
- Patent Title: Transcutaneous haemophilus influenzae vaccine formulations and methods
-
Application No.: US14773556Application Date: 2014-03-10
-
Publication No.: US09855326B2Publication Date: 2018-01-02
- Inventor: Lauren O. Bakaletz
- Applicant: RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL
- Applicant Address: US OH Columbus
- Assignee: Research Institute at Nationwide Children's Hospital
- Current Assignee: Research Institute at Nationwide Children's Hospital
- Current Assignee Address: US OH Columbus
- Agency: Marshall, Gerstein & Borun LLP
- International Application: PCT/US2014/022871 WO 20140310
- International Announcement: WO2014/138748 WO 20140912
- Main IPC: A61K39/102
- IPC: A61K39/102 ; A61K9/00 ; A61K9/70 ; A61K39/385 ; A61K39/00

Abstract:
Provided are topical delivery systems and methods for treating and/or preventing a disease or disorder in a subject, or for eliciting an immune response in a subject, including applying, to at least a portion of the subject's post-auricular region, a topical delivery system including a therapeutically effective amount of a topical pharmaceutical composition comprising at least one active agent and a pharmaceutically acceptable carrier and/or adjuvant. The topical pharmaceutical composition can include a topical immunogenic composition. The topical delivery system can further include a flexible substrate in communication with the topical immunogenic composition. The subject can be a pediatric subject.
Public/Granted literature
- US20160022800A1 TRANSCUTANEOUS DOSAGE FORMULATION Public/Granted day:2016-01-28
Information query